Thyroid Cancer In Pediatrics.
Published 2016 · Medicine
Download PDFAnalyze on Scholarcy
Well differentiated thyroid cancer (DTC) in children is characterized by a high rate of response to treatment and low disease-specific mortality. Treatment of children with DTC has evolved toward a greater reliance on evaluation and monitoring with serial serum thyroglobulin measurements and ultrasound examinations. Radioiodine therapy is recommended for thyroid remnant ablation in high-risk patients, treatment of demonstrated radioiodine-avid local-regional disease not amenable to surgical resection, or distant radioiodine-avid metastatic disease. Sufficient time should be given for benefits of radioiodine therapy to be realized, with follow-up monitoring. Re-treatment with radioiodine can be deferred until progression of significant disease manifests.
This paper references
Thyroid Incidentalomas: Management Approaches to Nonpalpable Nodules Discovered Incidentally on Thyroid Imaging
G. H. Tan (1997)
Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.
Narayanan Gopalakrishna Iyer (2011)
The usual ultrasonographic features of thyroid cancer are less frequent in small tumors that develop after a long latent period after the Chernobyl radiation release accident.
Valentina M. Drozd (2009)
Long-term follow-up of patients with initially benign thyroid fine-needle aspirations.
Yair Liel (2001)
Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients.
Massimo Eugenio Dottorini (1997)
Pediatric thyroid fine-needle aspiration cytology: a meta-analysis
Erica Eugster (2010)
The diagnostic value for differentiated thyroid carcinoma metastases of thyroglobulin (Tg) measurement in washout fluid from fine-needle aspiration biopsy of neck lymph nodes is maintained in the presence of circulating anti-Tg antibodies.
Francesco Boi (2006)
Comparison of (123)I and (131)I for whole-body imaging in thyroid cancer.
Salil D. Sarkar (2002)
Prognosis and prognostic factors for distant metastases and tumor mortality in follicular thyroid carcinoma.
Kiminori Sugino (2011)
Initial management and follow-up of differentiated thyroid cancer in children.
Steven G. Waguespack (2010)
Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
David S. Cooper (2009)
Thyroglobulin detection in fine-needle aspirates of cervical lymph nodes: a technique for the diagnosis of metastatic differentiated thyroid cancer.
Nuno Cunha (2007)
Differentiated thyroid carcinomas in children and adolescents.
Aban M Samuel (1991)
Thyroid Cancer in Children: Management and Outcome Experience of a Referral Center
Aron Popovtzer (2006)
Second primary malignancies in thyroid cancer patients
Corrado Rubino (2003)
Pregnancy After High Therapeutic Doses of Iodine-131 in Differentiated Thyroid Cancer: Potential Risks and Recommendations
Dario Casara (1993)
Outcomes and prognostic factors of 251 patients with minimally invasive follicular thyroid carcinoma.
Kiminori Sugino (2012)
Recombinant Human TSH–Assisted Radioactive Iodine Remnant Ablation Achieves Short-Term Clinical Recurrence Rates Similar to Those of Traditional Thyroid Hormone Withdrawal
Matthias Schott (2008)
A single recombinant human thyrotropin-stimulated serum thyroglobulin measurement predicts differentiated thyroid carcinoma metastases three to five years later.
Richard T. Kloos (2005)
Thyroid cancer in children.
Catherine A. Dinauer (2007)
A comparison of recombinant human thyrotropin and thyroid hormone withdrawal for the detection of thyroid remnant or cancer.
B Haugen (1999)
Response to sorafenib in a pediatric patient with papillary thyroid carcinoma with diffuse nodular pulmonary disease requiring mechanical ventilation.
Pallavi Iyer (2014)
Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
Barbara Jarzab (2005)
Historical note: TSH suppression for thyroid cancer.
James Ross Hurley (2011)
The indications for ablating normal thyroid tissue with 131I in differentiated thyroid cancer.
A. W. G. Goolden (1985)
Pathogenesis, diagnosis and management of thyroid nodules in children.
Marek Niedziela (2006)
European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium.
Furio Pacini (2006)
Change of serum antithyroglobulin antibody levels is useful for prediction of clinical recurrence in thyroglobulin-negative patients with differentiated thyroid carcinoma.
Won Gu Kim (2008)
Disappearance of Humoral Thyroid Autoimmunity after Complete Removal of Thyroid Antigens
Luca Chiovato (2003)
Minimally invasive follicular thyroid cancer (MIFTC)—a consensus report of the European Society of Endocrine Surgeons (ESES)
Gianlorenzo Dionigi (2013)
Factors influencing the basal and recombinant human thyrotropin-stimulated serum thyroglobulin in patients with metastatic thyroid carcinoma.
Richard J Robbins (2004)
Pathology and genetics of thyroid carcinoma.
Ronald A DeLellis (2006)
The successful use of sorafenib to treat pediatric papillary thyroid carcinoma.
Steven G. Waguespack (2009)
Differentiated thyroid carcinoma: defining new paradigms for postoperative management.
Cosimo Durante (2013)
Current Strategies for Surgical Management and Adjuvant Treatment of Childhood Papillary Thyroid Carcinoma
Geoffrey Thompson (2004)
Total Thyroidectomy and Adjuvant Radioiodine Treatment Independently Decrease Locoregional Recurrence Risk in Childhood and Adolescent Differentiated Thyroid Cancer
Daria Handkiewicz-Junak (2007)
Thyroid Cancer in Childhood Cancer Survivors: A Detailed Evaluation of Radiation Dose Response and its Modifiers
Cécile M. Ronckers (2006)
Positive predictive value of serum thyroglobulin levels, measured during the first year of follow-up after thyroid hormone withdrawal, in thyroid cancer patients.
Eric Baudin (2003)
Recurrence detection in differentiated thyroid cancer patients with elevated serum level of antithyroglobulin antibody: special emphasis on using (18)F-FDG PET/CT.
Ji Hyoung Seo (2010)
Long-term clinical outcome of differentiated thyroid cancer patients with undetectable stimulated thyroglobulin level one year after initial treatment.
Ji Min Han (2012)
Ultrasound criteria of malignancy for cervical lymph nodes in patients followed up for differentiated thyroid cancer.
Sophie Leboulleux (2007)
An overview of the management of papillary and follicular thyroid carcinoma.
Ernest L. Mazzaferri (1999)
A prospective study of thyroid nodular disease in children and adolescents in western Poland from 1996 to 2000 and the incidence of thyroid carcinoma relative to iodine deficiency and the Chernobyl disaster.
Marek Niedziela (2004)
Diagnosis of thyroid cancer in children: value of gray-scale and power doppler US.
Andrej Lyshchik (2005)
Management of thyroid cancer: radioiodine ablation, "stunning," and treatment of thyroglobulin-positive, (131)I scan-negative patients.
James Ross Hurley (2000)
Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.
Frederik Anton Verburg (2013)
Does amifostine have radioprotective effects on salivary glands in high-dose radioactive iodine-treated differentiated thyroid cancer
Chao Ma (2009)
Approach and safety of comprehensive central compartment dissection in patients with recurrent papillary thyroid carcinoma.
Gary L Clayman (2009)
Testicular dose and fertility in men following I(131) therapy for thyroid cancer.
Stephen Hyer (2002)
who receive radioactive iodine therapy
AM Sawka (2011)
Evolving approaches to patients with advanced differentiated thyroid cancer.
B Haugen (2013)
Complications of radioactive iodine treatment of thyroid carcinoma.
Stephanie L. Lee (2010)
Treatment of Recurrent Papillary Thyroid Carcinoma in Children and Adolescents
Patricia A.G. Powers (2003)
Systematic review and meta-analysis.
Miguel Delgado-Rodríguez (2018)
Rising incidence of second cancers in patients with low - risk ( T 1 N 0 )
Recombinant human thyrotropin-stimulated serum thyroglobulin combined with neck ultrasonography has the highest sensitivity in monitoring differentiated thyroid carcinoma.
Furio Pacini (2003)
Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma.
Carole A. Spencer (1998)
Response to sorafenib in a pediatric patient with papillary thyroid carcinoma with diffuse nodular pulmonary disease requiring mechanical ventilation.
Clinical review: Clinical utility of thyroglobulin antibody (TgAb) measurements for patients with differentiated thyroid cancers (DTC).
Carole A. Spencer (2011)
Does radioiodine therapy have disadvantageous effects in non-iodine accumulating differentiated thyroid carcinoma?
Jeroen Schaap (2002)
Oedema of the neck after ablation of the thyroid with radioactive iodine.
A. W. G. Goolden (1986)
EANM Dosimetry Committee series on standard operational procedures for pre-therapeutic dosimetry I: blood and bone marrow dosimetry in differentiated thyroid cancer therapy
Michael Lassmann (2008)
The Chernobyl thyroid cancer experience: pathology.
Virginia A. Livolsi (2011)
Management of paediatric thyroid carcinoma: recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy.
W. F. Eddie Lau (2006)
Differentiated thyroid cancer
Ajay Kumar (2003)
Long-term impact of initial surgical and medical therapy on papillary and follicular thyroid cancer.
Ernest L. Mazzaferri (1994)
Recurrence and morbidity in differentiated thyroid carcinoma in children.
Michael La Quaglia (1988)
Thyroid-hormone therapy and thyroid cancer: a reassessment
Bernadette Biondi (2005)
Does lemon candy decrease salivary gland damage after radioiodine therapy for thyroid cancer?
Kunihiro Nakada (2005)
Recombinant human thyroid stimulating hormone-assisted radioactive iodine remnant ablation in thyroid cancer patients at intermediate to high risk of recurrence.
Jonathan Hugo (2012)
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer.
Gary L. Francis (2015)
Usefulness of recombinant human thyrotropin in the radiometabolic treatment of selected patients with thyroid cancer.
Gabriella Pellegriti (2001)
The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer.
Richard S. Benua (1962)
Thyroid cancer in childhood: a retrospective review of childhood course.
Clodagh S M O'Gorman (2010)
Pulmonary fibrosis following radioiodine therapy of pulmonary metastases from differentiated thyroid carcinoma.
Libo Chen (2010)
American Association of Clinical Endocrinologists and Associazione Medici Endocrinologi medical guidelines for clinical practice for the diagnosis and management of thyroid nodules.
H. Gharib (2006)
Diagnostic value of serum thyroglobulin measurements in the follow-up of differentiated thyroid carcinoma, a structured meta-analysis.
Carmen F A Eustatia-Rutten (2004)
Role of neck ultrasonography in the follow-up of children operated on for thyroid papillary cancer.
Alessandro Antonelli (2003)
Second neoplasms in survivors of childhood cancer: findings from the Childhood Cancer Survivor Study cohort.
Anna T. Meadows (2009)
Global variation in the pattern of differentiated thyroid cancer.
Stacey L Woodruff (2010)
Assessment of female fertility and carcinogenesis after iodine-131 therapy for differentiated thyroid carcinoma.
Massimo Eugenio Dottorini (1995)
A systematic review examining the effects of therapeutic radioactive iodine on ovarian function and future pregnancy in female thyroid cancer survivors.
Anna M Sawka (2008)
Very high prevalence of thyroid nodules detected by high frequency (13 MHz) ultrasound examination.
Sabine Guth (2009)
Clinical review: improving the measurement of serum thyroglobulin with mass spectrometry.
Andrew N Hoofnagle (2013)
Differentiated thyroid cancer in children and adolescents: clinical outcome and mortality after long-term follow-up.
R. Vassilopoulou-sellin (1998)
Diagnosis and management of thyroid carcinoma: a focus on serum thyroglobulin
Stefan K. G. Grebe (2009)
Is the UICC/AJCC classification of primary tumor in childhood thyroid carcinoma valid?
Jamshid Farahati (1999)
Accuracy of fine needle aspiration biopsy of thyroid nodules in detecting malignancy in childhood: comparison with conventional clinical, laboratory, and imaging approaches.
Andrea Corrias (2001)
Childhood thyroid cancer in Belarus, Russia, and Ukraine after Chernobyl and at present.
Yuri E. Demidchik (2007)
Oncofertility and preservation of reproductive capacity in children and young adults.
W. Hamish B. Wallace (2011)
Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children
Barbara Jarzab (2000)
Lung transplantation for pulmonary metastases and radiation-induced pulmonary fibrosis after radioactive iodine ablation of extensive lung metastases from papillary thyroid carcinoma.
James S Lee (2007)
Applying the radioactive eraser: I-131 to ablate normal thyroid tissue in patients from whom thyroid cancer has been resected.
James C. Sisson (1983)
Diagnosis of neck recurrences in patients with differentiated thyroid carcinoma.
Andrea Frasoldati (2003)
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial
Marcia S. Brose (2014)
Significance of antithyroglobulin autoantibodies in differentiated thyroid carcinoma.
Ajay Kumar (1994)
Positron emission tomography and positron emission tomography-CT evaluation for recurrent papillary thyroid carcinoma: meta-analysis and literature review.
Mia E Miller (2011)
Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis.
Anna M Sawka (2009)
A Comparison Between Diagnostic I-123 and Posttherapy I-131 Scans in the Detection of Remnant and Locoregional Thyroid Disease
Damita L Thomas (2009)
Twenty-five years after Chernobyl: outcome of radioiodine treatment in children and adolescents with very high-risk radiation-induced differentiated thyroid carcinoma.
Christoph Reiners (2013)
Correlation Between Cervical Uptake and Results of Postsurgical Radioiodine Ablation in Patients With Thyroid Carcinoma
Pedro Weslley Rosario (2004)
Therapeutic impact of 18FDG-PET/CT in the management of iodine-negative recurrence of differentiated thyroid carcinoma.
E Mirallié (2007)
A systematic review of the gonadal effects of therapeutic radioactive iodine in male thyroid cancer survivors.
Anna M Sawka (2008)
Metastatic Differentiated Thyroid Carcinoma: ClinicopathologicalProfile and Outcome in an Iodine Deficient Area
Anjali Mishra (2001)
Pulmonary metastases in children and adolescents with well-differentiated thyroid cancer.
Aban M Samuel (1998)
Dosimetry-guided high-activity 131I therapy in patients with advanced differentiated thyroid carcinoma: initial experience
Frederik A. Verburg (2009)
Influence of thyroid-stimulating hormone levels on uptake of FDG in recurrent and metastatic differentiated thyroid carcinoma.
Ferdinand Peter Moog (2000)
A clinicopathologic study of minimally invasive follicular carcinoma of the thyroid gland with a review of the English literature.
Lester D. R. Thompson (2001)
Testicular function in patients with differentiated thyroid carcinoma treated with radioiodine.
Furio Pacini (1994)
Follicular thyroid carcinoma
Ksenija Krgović (2003)
Risk Factors in Follicular Thyroid Carcinomas: A Retrospective Follow-up Study Covering a 14-Year Period with Emphasis on Morphological Findings
Winfried Lang (1986)
Drug-induced changes in the biologic distribution of radiopharmaceuticals.
W B Hladik (1982)
Follicular adenoma and carcinoma of the thyroid gland.
C. R. Mchenry (2011)
Thyroid nodules and cancer in children and adolescents affected by autoimmune thyroiditis.
Andrea Corrias (2008)
Development and clinical impact of thyroglobulin antibodies in patients with differentiated thyroid carcinoma during the first 3 years after thyroidectomy.
Rainer Görges (2005)
Papillary Thyroid Carcinoma: A 10 Year Follow-Up Report of the Impact of Therapy in 576 Patients
Heno . Nevotlo (1981)
Management Guidelines for Children with Thyroid Nodules and Differentiated Thyroid Cancer
L FrancisGary (2015)
The role of positron emission tomography and positron emission tomography/computed tomography in thyroid tumours: an overview
Giorgio Treglia (2012)
Clinical implications of the differences between diagnostic 123I and post-therapy 131I scans
Jason B Cohen (2004)
Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: is there a role for serum thyroglobulin measurement?
Cosimo Durante (2012)
Long-term outcome of comprehensive central compartment dissection in patients with recurrent/persistent papillary thyroid carcinoma.
Gary L Clayman (2011)
Differentiated thyroid cancer in children and adolescents
Jamshid Farahati (1998)
Suspiciously malignant findings on ultrasound after fine needle aspiration biopsy in a thyroid nodule with initially benign ultrasound and cytologic result: to repeat or to follow-up.
Yu-Mee Sohn (2011)
Detection of recurrent papillary thyroid carcinoma by thyroglobulin assessment in the needle washout after fine-needle aspiration of suspicious lymph nodes.
Henry J. Baskin (2004)
Evidence-based Review of Treatment and Follow up of Pediatric Patients with Differentiated Thyroid Carcinoma
Marianna Rachmiel (2006)
Favourable course of disease after incomplete remission on 131I therapy in children with pulmonary metastases of papillary thyroid carcinoma: 10 years follow-up
Johannes Biko (2010)
Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131I : practice recommendations of the American Thyroid Association.
James C. Sisson (2011)
Success of the postoperative 131I therapy in young Belarusian patients with differentiated thyroid cancer after Chernobyl depends on the radiation absorbed dose to the blood and the thyroglobulin level
Heribert Haenscheid (2011)
Differentiated thyroid carcinoma in childhood and adolescence-clinical course and role of radioiodine.
Sin-Ming Chow (2004)
Comparison of the distribution of diagnostic and thyroablative I-131 in the evaluation of differentiated thyroid cancers.
Jan Němec (1979)
Subsequent fertility and birth histories of children and adolescents treated with 131I for thyroid cancer.
Salil D. Sarkar (1976)
Pediatric surgical images: PET evaluation of papillary thyroid carcinoma recurrence.
Simon Armstrong (2002)
Functioning pulmonary metastases of thyroid cancer: does radioiodine influence the prognosis?
Elif Hindié (2003)
A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.
Ernest L. Mazzaferri (2003)
Measurement of serum TSH and thyroid hormones in the management of treatment of thyroid carcinoma with radioiodine.
Caroline J. Edmonds (1977)
New therapeutic advances in the management of progressive thyroid cancer.
Jennifer A Woyach (2009)
Undetectable sensitive serum thyroglobulin (<0.1 ng/ml) in 163 patients with follicular cell-derived thyroid cancer: results of rhTSH stimulation and neck ultrasonography and long-term biochemical and clinical follow-up.
Ana Maria Chindriş (2012)
Salivary gland malignancy and radioiodine therapy for thyroid cancer.
Joanna Klubo-Gwiezdzinska (2010)
Salivary Gland Side Effects Commonly Develop Several Weeks After Initial Radioactive Iodine Ablation
Ravinder Kaur Grewal (2009)
Clinical significance of elevated level of serum antithyroglobulin antibody in patients with differentiated thyroid cancer after thyroid ablation.
J-K Chung (2002)
Robert Michael Tuttle (2010)
Pathology and genetics of tumours of endocrine organs
Ronald A DeLellis (2004)
Differentiated thyroid cancer: determinants of disease progression in patients <21 years of age at diagnosis: a report from the Surgical Discipline Committee of the Children's Cancer Group.
Kurt D. Newman (1998)
Thyroid cancer in children: the Royal Marsden Hospital experience.
Daryl Landau (2000)
The use of dosimetry in the treatment of differentiated thyroid cancer.
Michael Lassmann (2011)
Diagnostic value of thyroglobulin assay in cervical lymph node fine-needle aspirations for metastatic differentiated thyroid cancer
Luca Giovanella (2013)
Utilization of Total Thyroidectomy for Differentiated Thyroid Cancer in Children
Mehul V. Raval (2010)
The Bethesda System for Reporting Thyroid Cytopathology
Dharmendra Kumar (2018)
Assessment of the influence of thyroglobulin (Tg) autoantibodies and other interfering factors on the use of serum Tg as tumor marker in differentiated thyroid carcinoma.
B Schaadt (1995)
Technology Insight: measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer
Carole A. Spencer (2008)
Radiation exposure from outpatient radioactive iodine (131I) therapy for thyroid carcinoma.
Perry Grigsby (2000)
Pulmonary metastases in children and young adults with differentiated thyroid cancer.
R. Vassilopoulou-sellin (1993)
Is the serum thyroglobulin response to recombinant human thyrotropin sufficient, by itself, to monitor for residual thyroid carcinoma?
Richard J Robbins (2002)
American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer : The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
Resistance of [18f]-fluorodeoxyglucose-avid metastatic thyroid cancer lesions to treatment with high-dose radioactive iodine.
Wenli Wang (2001)
False-positive findings on (131)I whole-body scans because of posttraumatic superficial scabs.
Concetto Regalbuto (2002)
Outcomes of children and adolescents with well-differentiated thyroid carcinoma and pulmonary metastases following ¹³¹I treatment: a systematic review.
Melissa Pawelczak (2010)
Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.
David S. Cooper (2006)
Pulmonary fibrosis in youth treated with radioiodine for juvenile thyroid cancer and lung metastases after Chernobyl
Helge Hebestreit (2011)
Comprehensive Clinical Assessment of 740 Cases of Surgically Treated Thyroid Cancer in Children of Belarus
Yuri E. Demidchik (2006)
Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients.
Anthony Richard Hogan (2009)
Cytomorphological and molecular genetic findings in pediatric thyroid fine-needle aspiration.
Sara E Monaco (2012)
Serum thyrotropin (TSH) levels after recombinant human TSH injections in children and teenagers with papillary thyroid cancer.
Sonia Iorcansky (2005)
Rapid rise in serum thyrotropin concentrations after thyroidectomy or withdrawal of suppressive thyroxine therapy in preparation for radioactive iodine administration to patients with differentiated thyroid cancer.
Dina I. Serhal (2004)
Operative strategy for follicular thyroid cancer in risk groups stratified by pTNM staging.
Jen-Der Lin (2007)
Nasolacrimal drainage system obstruction from radioactive iodine therapy for thyroid carcinoma.
Richard T. Kloos (2002)
The effects of gonadal irradiation in clinical radiation therapy: a review.
Clarence C. Lushbaugh (1976)
Commentary on: Implications of thyroglobulin antibody positivity in patients with differentiated thyroid cancer: a clinical position statement.
Carole A. Spencer (2013)
The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
Aaron P. Brown (2008)
Differentiated thyroid cancer: clinical characteristics, treatment, and outcome in patients under 21 years of age who present with distant metastases. A report from the Surgical Discipline Committee of the Children's Cancer Group.
Michael La Quaglia (2000)
Diagnosis of Thyroid Cancer in Children
Andrej Lyshchik (2008)
Comparison of administration of recombinant human thyrotropin with withdrawal of thyroid hormone for radioactive iodine scanning in patients with thyroid carcinoma.
Paul Ladenson (1997)
Pediatric Graves’ Disease: Controversies in Management
Scott A. Rivkees (2010)
Thyrotropin suppression and disease progression in patients with differentiated thyroid cancer: results from the National Thyroid Cancer Treatment Cooperative Registry.
David S. Cooper (1998)
Characteristics of differentiated thyroid carcinoma in children and adolescents with respect to age, gender, and histology.
Jamshid Farahati (1997)
STRUCTURAL CHANGES IN THE THYROID GLANDS OF HEALTHY YOUNG MEN.
James E. Oertel (1965)
Predictive factors of malignancy in pediatric thyroid nodules.
Rashmi Roy (2011)
Diagnostic 131-iodine whole-body scan may be avoided in thyroid cancer patients who have undetectable stimulated serum Tg levels after initial treatment.
Furio Pacini (2002)
Approach to the patient: role of dosimetric RAI Rx in children with DTC.
Frederik Anton Verburg (2013)
The prognostic value of primary tumor size in papillary and follicular thyroid carcinoma.
Andreas Machens (2005)
Self-stunning in thyroid ablation: evidence from comparative studies of diagnostic 131I and 123I
Thomas E. Hilditch (2002)
Approach to the pediatric patient with Graves' disease: when is definitive therapy warranted?
Andrew J Bauer (2011)
Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies. 1995.
Elaine Ron (2012)
Radioiodine treatment of thyroid cancer with the aid of recombinant human thyrotropin.
M L Adler (1998)
Papillary thyroid cancer with pulmonary metastases in children: long-term prognosis.
Jeromy S. Brink (2000)
Effects of low-iodide diet on postsurgical radioiodide ablation therapy in patients with differentiated thyroid carcinoma.
Maurice J H M Pluijmen (2003)
Tumor Size and Extent of Disease at Diagnosis Predict the Response to Initial Therapy for Papillary Thyroid Carcinoma in Children and Adolescents
Patricia A.G. Powers (2003)
Limited value of repeat recombinant human thyrotropin (rhTSH)-stimulated thyroglobulin testing in differentiated thyroid carcinoma patients with previous negative rhTSH-stimulated thyroglobulin and undetectable basal serum thyroglobulin levels.
Maria Grazia Castagna (2008)
Radioactive iodine therapy; effect on functioning metastases of adenocarcinoma of the thyroid.
S. M. Seidlin (1946)
Lenvatinib versus placebo in radioiodine-refractory thyroid cancer.
Martin G. Schlumberger (2015)
Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablation.
Camila Nascimento (2013)
Comparison of I-123 and I-131 for Whole-Body Imaging After Stimulation by Recombinant Human Thyrotropin: A Preliminary Report
Gregory D. S. Anderson (2003)
Value of 18F-FDG-PET/PET-CT in differentiated thyroid carcinoma with radioiodine-negative whole-body scan: a meta-analysis
Meng-Jie Dong (2009)
A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults.
Anjuli Gupta (2013)
The treatment of differentiated thyroid cancer in children: emphasis on surgical approach and radioactive iodine therapy.
Scott A. Rivkees (2011)
Prognostic impact of serum thyroglobulin doubling-time under thyrotropin suppression in patients with papillary thyroid carcinoma who underwent total thyroidectomy.
Akira Miyauchi (2011)
Age- and sex-adjusted iodine/creatinine ratio. A new standard in epidemiological surveys? Evaluation of three different estimates of iodine excretion based on casual urine samples and comparison to 24 h values
N Knudsen (2000)
Prognosis for fertility and ovarian function after treatment with radioiodine for thyroid cancer
Louiza Vini (2002)
Total-body scintigraphy with thallium-201 and iodine-131 in the follow-up of differentiated thyroid cancer.
José Manuel Carril (1997)
The treatment of thyroid carcinoma with radioactive iodine.
William H. Beierwaltes (1978)
Fertility and birth histories of patients treated with I-131 for thyroid cancer before 1969 at 20 years or less
SD Sarkar (1976)
A phase II trial of doxorubicin and interferon alpha 2b in advanced, non-medullary thyroid cancer
Athanassios Argiris (2007)
Real-time prognosis for metastatic thyroid carcinoma based on 2-[18F]fluoro-2-deoxy-D-glucose-positron emission tomography scanning.
Richard J Robbins (2006)
Iodine-123 as a diagnostic imaging agent in differentiated thyroid carcinoma: a comparison with iodine-131 post-treatment scanning and serum thyroglobulin measurement
Muammer Urhan (2006)
Does an undetectable rhTSH-stimulated Tg level 12 months after initial treatment of thyroid cancer indicate remission?
Joanna Kłubo-Gwieździńska (2011)
Current controversies in the management of pediatric patients with well-differentiated nonmedullary thyroid cancer: a review.
Wellington Hung (2002)
Recombinant thyrotropin use in children and adolescents with differentiated thyroid cancer: a multicenter retrospective study.
Markus Luster (2009)
Long-Term Outcome in 215 Children and Adolescents with Papillary Thyroid Cancer Treated During 1940 Through 2008
Ian D. Hay (2009)
Testicular function after radioiodine therapy for thyroid carcinoma
Maria Wichers (2000)
STRUCTURAL CHANGES IN THE THYROID GLANDS OF HEALTHY YOUNG MEN.
Oertel Je (1965)
Empiric radioactive iodine dosing regimens frequently exceed maximum tolerated activity levels in elderly patients with thyroid cancer.
Robert Michael Tuttle (2006)
Is nodule size an independent predictor of thyroid malignancy?
C. R. Mchenry (2008)
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
B Haugen (2016)
Clinical features associated with metastasis and recurrence of differentiated thyroid cancer in children, adolescents and young adults.
C A Welch Dinauer (1998)
Diminishing diagnosis of follicular thyroid carcinoma.
Kristen J. Otto (2010)
Comparative evaluation of recombinant human thyrotropin-stimulated thyroglobulin levels, 131I whole-body scintigraphy, and neck ultrasonography in the follow-up of patients with papillary thyroid microcarcinoma who have not undergone radioiodine therapy.
Massimo Torlontano (2006)
Childhood and adolescent thyroid carcinoma.
Perry Grigsby (2002)
Thyroid fine-needle aspiration biopsy in children and adolescents: experience with 218 aspirates.
Mojghan Amrikachi (2005)
Gonadal damage from 131I therapy for thyroid cancer.
Ernest L. Mazzaferri (2002)
Management of papillary and follicular (differentiated) thyroid cancer: new paradigms using recombinant human thyrotropin.
Ernest L. Mazzaferri (2002)
Risk Factors for Lateral Cervical Lymph Node Involvement in Follicular Thyroid Carcinoma
Haitham Alfalah (2008)
Natural history, treatment, and course of papillary thyroid carcinoma.
Leslie J. Degroot (1990)
Low Iodine Diet in I-131 Ablation of Thyroid Remnants
Harry R. Maxon (1983)
Indeterminate Pediatric Thyroid Fine Needle Aspirations: A Study of 68 Cases
Matthew A. Smith (2013)
This paper is referenced by
Nuclear Medicine in Pediatrics
Pietro Zucchetta (2019)
Patologia quirúrgica de la glándula tiroides en pacientes pediátricos
Juan Oré (2019)
Up-regulated lipocalin-2 in pediatric thyroid cancer correlated with poor clinical characteristics
Jun Tai (2018)
Thyroid Ultrasound: More Sensitive than Radioactive Iodine Imaging in Detecting Recurrence of Papillary Thyroid Cancer in Two Pediatric Patients
Brittany K Wise-Oringer (2018)
Pediatric Differentiated Thyroid Cancer: Our Experience
Wafaa Abd Elhameed Elsayed (2019)
Incidence and malignancy rates of indeterminate pediatric thyroid nodules
Huiying Wang (2019)